Posted in | Nanobusiness

New Breed of Bio-nano Firms is Creating a Novel and Profitable Business Cycle

A new breed of technology start-up companies is creating a novel and potentially very profitable business cycle.

Beedie School of Business researchers Armstrong Murira (left), Elicia Maine and V.J. Thomas have published the first study on a new breed of businesses called bio-nano firms.

Elicia Maine, a Beedie School of Business associate professor, is among the first to identify, classify and analyze “de nova firms”—technology start-ups borne of tightly integrated industry and university research labs.

Maine says the firms are driving invention at the crossroads of nanotechnology and biotechnology that, in turn, is energizing many economic sectors such as business investment and manufacturing.

She led a recent study that identifies more than 500 of the world’s first de nova companies. The data shows these companies are taking hold not just in technology hotbeds such as California’s Silicon Valley and the northeastern U.S. but across the continent and in Europe.

“We have watched the ecosystem emerge in terms of the number and type of firms entering,” says Maine.

“This confluence of technology silos in the emerging bio-nano sector is enabling radical innovation, new products and connections that didn’t exist before.

“Some of the things we’re talking about are targeted drug delivery, tissue engineering, enhanced medical diagnostics and new therapeutics.”

From 2005-11, the number of bio-nano firms nearly doubled, to 507, with more than 100 of them emerging in North America alone. For more, visit:


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback